GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunniva Inc (XCNQ:SNN) » Definitions » EV-to-EBIT

Sunniva (XCNQ:SNN) EV-to-EBIT : -0.16 (As of Sep. 22, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Sunniva EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Sunniva's Enterprise Value is C$6.08 Mil. Sunniva's EBIT for the trailing twelve months (TTM) ended in Sep. 2019 was C$-37.85 Mil. Therefore, Sunniva's EV-to-EBIT for today is -0.16.

The historical rank and industry rank for Sunniva's EV-to-EBIT or its related term are showing as below:

XCNQ:SNN's EV-to-EBIT is not ranked *
in the Drug Manufacturers industry.
Industry Median: 16.175
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Sunniva's Enterprise Value for the quarter that ended in Sep. 2019 was C$106.63 Mil. Sunniva's EBIT for the trailing twelve months (TTM) ended in Sep. 2019 was C$-37.85 Mil. Sunniva's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2019 was -35.50%.


Sunniva EV-to-EBIT Historical Data

The historical data trend for Sunniva's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunniva EV-to-EBIT Chart

Sunniva Annual Data
Trend Dec16 Dec17 Dec18
EV-to-EBIT
- - -5.01

Sunniva Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.78 -5.01 -7.96 -4.16 -2.82

Competitive Comparison of Sunniva's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Sunniva's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunniva's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sunniva's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sunniva's EV-to-EBIT falls into.



Sunniva EV-to-EBIT Calculation

Sunniva's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=6.077/-37.849
=-0.16

Sunniva's current Enterprise Value is C$6.08 Mil.
Sunniva's EBIT for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-37.85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sunniva  (XCNQ:SNN) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Sunniva's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2019 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2019 ) =EBIT / Enterprise Value (Q: Sep. 2019 )
=-37.849/106.62619
=-35.50 %

Sunniva's Enterprise Value for the quarter that ended in Sep. 2019 was C$106.63 Mil.
Sunniva's EBIT for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-37.85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sunniva EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Sunniva's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Sunniva Business Description

Traded in Other Exchanges
N/A
Address
200 Burrard Street, 1200 Waterfront Centre, P.O Box 48600, Vancouver, BC, CAN, V7X 1T2
Sunniva Inc is vertically integrated medical cannabis company committed to delivering safe, low-cost, high-quality products and services at scale. The company is focused on the cultivation, production and distribution of therapeutic solutions targeting two of the medical cannabis markets in the world: Canada and California.
Executives
Mark Hamish Kimmins Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)

Sunniva Headlines

From GuruFocus

Smith & Nephew: A Medical Equipment Opportunity

By The City Letter 08-09-2022

Smith & Nephew Is Reverting to Fair Value

By Praveen Chawla 01-25-2023